SEC Form D private-offering filing

CND Life Sciences, Inc.

Name: CND Life Sciences, Inc. - new SEC Form D private-offering filing, Scottsdale, AZ
Published: 2026-06-16

A new SEC Form D private-offering notice from Scottsdale, AZ, a $6,250,000 filer-stated offering target in Biotech. The source filing is one click away.

CND Life Sciences, Inc. site↗ Verified via SEC Form D

Neurodiagnostics company that makes the Syn One Test, a skin biopsy based diagnostic aid for Parkinson's disease and related neurodegenerative disorders.

Filed 2026-06-16Filed to raise $6,250,000First money in 2026-06-09Raised so far $4,314,750HQ (as filed) Scottsdale, AZSector Biotech ✓Stage (inferred) EarlyCall status Debt-only offering

Source linked the Form D on EDGAR↗Website verified cndlifesciences.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in Arizona →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.